Fmg was losing at one stage, they have volume in their favour to cut costs, ARI does 7-8mill tonns, harder to strip costs on small volume.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%